10/18/2016 - 3:34pm

The portfolio Upsher-Smith acquires contains 19 solid-oral dosage products and one nasal product, all of which have been approved by the Food and Drug Administration but haven’t been marketed by Sandoz.

10/18/2016 - 2:56pm

Forbes is reporting that that Lannett’s shares fell 12.9% on Monday following an announcement from the FDA that it would be withdrawing approval of Lannett’s Concerta generic. The drug treats attention deficit hyperactivity disorder, and the FDA said there might not be enough evidence that Lannett’s generic is bioequivalent to the reference product. (Forbes)

10/18/2016 - 1:11pm

Amneal’s Yuvafem delivers the same low dose of vaginal estrogen as Vagifem, and is packaged in 8- and 18-count sizes. 

10/18/2016 - 12:50pm
Inflectra will be the second biosimilar available in the United States, and the first biosimilar monoclonal antibody. 
10/17/2016 - 5:25pm

Drug overdoses have become the leading cause of accidental death in the United States, with 47,055 people dying in 2014 as a result of lethal drug overdoses — 18,893 of which were related to prescription pain relievers. One of the critical first lines of defense, the drug naloxone can reverse the effects of an overdose. But until recently it could only be accessed by prescription.

10/13/2016 - 2:55pm

Beyaz had U.S. sales of about $134 million for the 12 months ended August 2016, according to IMS Health data. 

10/13/2016 - 11:48am

The HDA seminar will host supply chain leaders — including distributors, manufacturers, pharmacists and third-party logistics providers — as well as federal/state regulators.

10/13/2016 - 11:31am

The Dr. Reddy’s generic will be available in 2-, 5-, 10-, 15-, 20- and 30-mg dosage strengths in 30-count bottles.

10/12/2016 - 12:12pm
The drug had $133 million in U.S. sales for the 12 months ended July 2016, according to IMS Health.